VentriPoint Diagnostics (TSE:VPT) has released an update.
Ventripoint Diagnostics has partnered with Empire Relations Group Inc. (ERG) to enhance investor relations, targeting professional investors interested in innovative medical technologies. Their agreement, subject to TSX Venture Exchange approval, includes an initial term with a possible three-month extension. Ventripoint, known for its AI-driven echocardiography advancements, aims to revolutionize heart imaging with their VMS products.
For further insights into TSE:VPT stock, check out TipRanks’ Stock Analysis page.
